Searched for
USFDA APPROVAL
Biocon gets USFDA nod for breast cancer biosimilar PebrilzoBiocon Ltd has announced receiving US FDA approval for their biosimilar Pebrilzo, which treats HER2-positive breast cancer. This milestone ...
Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatmentLupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve ac...
Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
Dr Reddy’s Q2 Results: Net profit falls 36% YoY to Rs 913 crore, revenue declines marginallyDr Reddy’s Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27, while revenue slipped 1.5%. North America ...
Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
Dr Reddy’s Laboratories receives two observations for Andhra Pradesh facilityThe US health regulator completed a Pre-Approval Inspection (PAI) at the company's FTO-11 manufacturing unit from October 5-7, Dr Reddy's L...
CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
Stocks in news: Tata Group, ITC, IRFC, NCC, Zydus Lifesciences and JSW EnergyThe Indian equity markets faced a significant downturn, with benchmark indices slipping past vital support thresholds. The Nifty 50 saw a d...
Stocks in news: RVNL, Lenskart, Mazagon Dock, Maruti Suzuki India and Nestle IndiaIndian equities concluded Friday's session with marginal gains, supported by softer crude prices. Several companies like RVNL and Mazagon D...
Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavirDr Reddy's Laboratories and Gilead Sciences have signed a licensing agreement. This pact involves investigational once-yearly lenacapavir f...
Stocks in news: Infosys, Mazagon Dock, Fortis Healthcare, JSW Energy and Kalpataru ProjectsOn September 16, Indian markets experienced a careful resurgence, with the Nifty and Sensex both moving upwards. This rebound was fueled by...
Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...
Zydus Lifesciences gets USFDA nod for generic ascorbic acid injectionZydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in sp...
Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepinessLupin received USFDA approval for generic Pitolisant Tablets, strengthening its US portfolio and specialty generics presence. Shares remain...
Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepinessPharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treatin...
Zydus Lifesciences shares in focus after 2 regulatory approvals from Health Canada, USFDAZydus Life shares: Zydus Lifesciences received regulatory approvals from Health Canada for generic Liothyronine tablets and from the USFDA ...
USFDA approves Glenmark Pharma's seizure treatment drugNew Delhi-based Glenmark's USFDA-approved 15 mg and 25 mg Topiramate capsules, equivalent to Janssen's Topamax, will be marketed by Glenmar...
Zydus Cadila gets USFDA nod for its ulcerative colitis drugThe company has received final approval from the USFDA for Mesalamine delayed-release tablets in the strength of 800 mg, Zydus Cadila said ...
- Jubilant Life's four medicines get USFDA approval
Jubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.
- Ranbaxy gets USFDA nod for to sell muscle relaxing tabs in US
Home-grown pharma major, Ranbaxy has received the US Food and Drug Administration's (USFDA) approval for selling cyclobenzaprine hydrochlor...